Caricamento...
Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT
The Chemohormonal Therapy vs Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED) was a randomized phase III trial that evaluated the outcomes of men with metastatic prostate cancer who received castration with or without docetaxel. Patients from this trial were gen...
Salvato in:
| Pubblicato in: | Cancer Biol Ther |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515525/ https://ncbi.nlm.nih.gov/pubmed/32791030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1796195 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|